Work

Abstract CT023: A phase 0/1 ‘trigger’ trial of BDTX-1535 in recurrent glioblastoma (GBM) patients with EGFR alterations or fusions

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct023

Authors: Nader Sanai, Yoshie Umemura, Vahuni Karapetyan, Tigran Margaryan, Dylan Huttenlocher, Brian Pham, Jocelyn Harmon, Amy Hong, Wonsuk Yoo, An-Chi Tien, Artak Tovmasyan, Shwetal Mehta

Institution: Barrow Neurological Institute

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409822441

Cites:

Cited by:

Related to: 10